FDA Beats EU On Cancer Drugs, But Not Others, Study Shows
The U.S. Food and Drug Administration gets new cancer medicines to patients more rapidly than other pharmaceuticals, and the opposite is true for the European Medicines Agency, according to a study...To view the full article, register now.
Already a subscriber? Click here to view full article